$4,667.80 travel Payment -- Gilead Sciences to Dr. Christopher Clark
This page provides a detailed analysis of a $4,667.80 travel payment from Gilead Sciences to Dr. Christopher Clark. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $4,667.80 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Gilead Sciences |
| Physician | Dr. Christopher Clark |
| NPI Number | 1933599093 |
| Physician Specialty | Hepatology |
| Location | Sacramento, CA |
| Date of Payment | 2026-02-20 |
| Related Drug/Device | Spinraza |
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Related Reports
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.